Eurofins Scientific SEERF
▲ PositiveCapitalrelevance
CEO-controlled entity buys shares, signaling insider confidence.
Impact on stocks 1
Health Care
Eurofins Scientific SEEurofins CEO-Controlled Entity Acquires Shares Over Three Days
Management
Analytical Bioventures S.C.A, a company controlled by Eurofins Scientific S.E. CEO Dr. Gilles Martin, has acquired a total of 6,000 shares of Eurofins Scientific S.E. across three separate transactions. The purchases were made on June 17, 18, and 19, 2026, each for 2,000 shares at prices of EUR 62.27000, EUR 62.1825, and EUR 62.746 respectively, resulting in a total investment of EUR 374,289.00. All transactions took place on the XPAR venue and were disclosed in accordance with the European Market Abuse Regulation.
Eurofins Scientific SECEO-controlled entity buys shares, signaling insider confidence.